NanoHive’s New Hive Zero Profile Standalone Cervical Cage
Boston, MA, January 9, 2023 /OrthoSpineNews/ – NanoHive Medical has acquired 510(okay) Clearance from the U.S Food and Drug Administration (FDA) for its Hive™ Standalone Cervical System. The implant system options each a zero profile design, interfixated with two self-tapping screws, in addition to a cage and plate fixation choice.
Each interbody cage choices can be found in a number of footprints, heights and lordoses to accommodate affected person anatomy and have the revolutionary Hive™ Tender Titanium® expertise.
Patrick O’Donnell, President & CEO of NanoHive Medical remarks that “This FDA Clearance represents a really thrilling and momentous achievement for the corporate. With the Q1, 2023 launch of the Hive™ Standalone Cervical System, mixed with our Hive™ Standalone Anterior Lumbar System, the corporate is positioned because the chief of 3D printed titanium anterior standalone fusion programs. Moreover, the brand new cervical system is ideally designed to handle the fast migration of cervical fusion procedures to ambulatory care surgical procedure middle amenities.
“NanoHive Medical, LLC is a pioneer and main innovator in 3D printed spinal interbody fusion implants and instrumentation. The corporate’s proprietary, biomimetic Tender Titanium® expertise clearly distinguishes their merchandise within the $1.9B spinal interbody fusion gadget market. The Hive™ portfolio of interbody fusion units present surgeons and their sufferers best biomechanical elastic modulus properties, clear and exact diagnostic imaging functionality, osteoblast cell attraction and integration – all options that result in constantly sturdy fusion constructs and efficacious medical experiences.
NanoHive Medical is positioned in Woburn, Massachusetts U.S.A
Contact: Patrick O’Donnell, CEO & President, Patrick.firstname.lastname@example.org
Web site: www.nanohive.com